Skip to main content
Home
Search
Multi-scale Atlas
NEW
Search for Drug ADMET Endpoint Profile (DAE)
NEW
Search for Drug Pharmacogenomic Perturbation Map (DPP)
NEW
Search for Drug-Molecule Activity Atlas (DMA)
NEW
Drug Development Portfolio
Search for Drug
Search for Combinatorial Drug (CBD)
Search for Repurposed Drug (RPD)
Drug-interacting Molecule
Search for Drug Therapeutic Target (DTT)
Search for Drug Transporter (DTP)
Search for Drug-Metabolizing Enzyme (DME)
Search for Drug Off-target (DOT)
Disease
Search for Disease
Download
Help
About
Details of the Drug Formulaction
General Information of Drug Formulation (ID: F23143)
Formulation Name
Ecallantide 10mg/ml injectable
Company
Dyax Corp
Pharmaceutical Drug(s) in Formulation
Drug Name
Drug ID
Indication
ICD 11
Status
Ecallantide
DMOF2C6
Retina venous occlusion
9B74.1
Approved
--------------------
Pharmaceutical Excipient(s) in Formulation
Excipient Name
Excipient ID
PubChem CID
Functional Classification
Disodium hydrogenorthophosphate
E00283
24203
Buffering agent; Complexing agent
Potassium chloride
E00074
4873
Tonicity agent
Potassium phosphate monobasic
E00429
516951
Buffering agent
Sodium chloride
E00077
5234
Diluent; Tonicity agent
--------------------